Company Search:
Advanced Search
Sponsored Links
Staidson (Beijing) Biopharmaceuticals Co Ltd Company Snapshot
Staidson (Beijing) Biopharmaceuticals Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Staidson (Beijing) Biopharmaceuticals Co Ltd with three other companies in this sector in China: Changsheng Bio-technology Co Ltd (2017 sales of 1.55 billion Chinese Renmimbi [US$245.36 million] of which 99% was Vaccine Sales), Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (1.11 billion Chinese Renmimbi [US$175.76 million] of which 97% was Pharmaceutical manufacture), and Zhejiang Wolwo Bio Pharmaceutical Co Ltd (385.58 million Chinese Renmimbi [US$60.90 million] of which 99% was Pharmaceutical Manufacturing).

Sales Analysis. Staidson (Beijing) Biopharmaceuticals Co Ltd reported sales of 1.39 billion Chinese Renmimbi (US$219.22 million) for the year ending December of 2017. This represents a decrease of 1.1% versus 2016, when the company's sales were 1.40 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Staidson (Beijing) Biopharmaceuticals Co Ltd
  Stock Performance Chart for Staidson (Beijing) Biopharmaceuticals Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 12.55
(Figures in Chinese Renmimbi)
1 Week -2.0%   13 Weeks 10.5%  
4 Weeks -12.3%   52 Weeks -28.0%  
Staidson (Beijing) Biopharmaceuticals Co Ltd Key Data:
  Ticker: 300204 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 1,387,885,910
(Year Ending Jan 2018).
Employees: 678
  Currency: Chinese Renmimbi Market Cap: 5,996,543,788
  Fiscal Yr Ends: December Shares Outstanding: 477,812,254
  Share Type: Gu A Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.